A nomogram for predicting survival of head and neck mucosal melanoma

被引:0
作者
Qing-Qing Xu
Qing-Jie Li
Liu Chen
Xin-Yi Su
Jing-Xia Song
Juan Du
Lei Chen
Li-Xia Lu
机构
[1] Sun Yat-Sen University Cancer Center,Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
[2] Tongji Medical College,Department of Radiation Oncology, Hubei Cancer Hospital
[3] Huazhong University of Science and Technology,undefined
来源
Cancer Cell International | / 21卷
关键词
Mucosal melanoma of the head and neck; Clinical outcomes; Prognostic factors; Nomogram;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 135 条
  • [1] Chang AE(1998)The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade Am Coll Surg Comm Cancer Am Cancer Soc Cancer 83 1664-1678
  • [2] Karnell LH(2000)Oral mucosal melanoma: epidemiology and pathobiology Oral Oncol 36 152-169
  • [3] Menck HR(2013)Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma J Pathol 230 261-269
  • [4] Hicks MJ(2014)Mucosal melanoma of the head and neck: a systematic review of the literature Int J Radiat Oncol Biol Phys 90 1108-1118
  • [5] Flaitz CM(2017)Mucosal melanoma of the head and neck Crit Rev Oncol Hematol 112 136-152
  • [6] Furney SJ(2008)Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma Oral Oncol 44 1039-1046
  • [7] Turajlic S(2020)PET-CT and occupational exposure in oncological patients Scimed J 2 63-69
  • [8] Stamp G(2019)Developing an integrated Genomic profile for cancer patients with the use of NGS data Emerg Sci J 3 157-167
  • [9] Nohadani M(2008)How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 1364-1370
  • [10] Carlisle A(2014)Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis Cancer 120 492-498